Editorials
Vol. 1 No. 1 (2011)
Pre-clinical anticancer drugs screening: perspectives from emerging models of glioma biology
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 8 December 2010
Accepted: 8 December 2010
Accepted: 8 December 2010
1191
Views
568
Downloads
317
HTML
Authors
Downloads
Download data is not yet available.
Citations
Supporting Agencies
Research in author's laboratory is supported by grants from the Swedish Research Council and the Karolinska Institute.How to Cite
Pre-clinical anticancer drugs screening: perspectives from emerging models of glioma biology. (2010). Drugs and Therapy Studies, 1(1), e1. https://doi.org/10.4081/dts.2011.e1